封面
市場調查報告書
商品編碼
2174153

全球動物腸道健康市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Animal Intestinal Health Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 219 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球動物腸道健康市場預計將從2025年的46.5億美元成長到2034年的85.9億美元,2026年至2034年的複合年成長率(CAGR)為7.06%。在人們對牲畜和伴侶動物腸道健康重要性認知不斷提高的推動下,動物腸道健康市場預計將迎來顯著成長。隨著全球對動物性蛋白質需求的不斷成長,生產商越來越重視最佳化動物健康和生產力,以確保永續生產。腸道健康在促進營養吸收、增強免疫力和降低疾病易感性方面的作用正日益受到重視,從而導致對促進腸道健康產品的需求激增。

益生菌、益生元和其他腸道健康補充劑的創新是推動市場擴張的關鍵。這些產品不僅支持消化系統健康,還有助於改善動物的整體健康狀況,這在當今競爭激烈的農業環境中至關重要。隨著天然和有機農業趨勢的興起,以及生產者努力減少抗生素和其他合成添加劑的使用,符合這些原則的腸道健康解決方案的需求正在進一步成長。

此外,通用感染疾病率的上升以及消費者對安全、高品質畜產品日益成長的需求,正促使生產商加大對動物健康解決方案的投資。監管壓力和遵守食品安全標準的必要性也是推動市場發展的關鍵因素。隨著研究不斷揭示腸道健康與動物整體生產力之間複雜的相互關係,動物腸道健康市場預計將迎來強勁成長,其重點在於開發能夠滿足不同動物物種特定需求的創新解決方案。

我們的報告經過精心撰寫,旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分,旨在幫助您全面了解市場環境:

市場概覽:本節對市場進行了清晰的說明,包括關鍵定義、分類以及當前行業格局的概述。

市場動態:對影響市場成長的主要促進因素、阻礙因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析:本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局:我們對主要市場參與企業進行了詳細評估,包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測:本部分提供基於數據的市場規模和成長模式預測,預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析,以識別未來預期趨勢。

區域分析:這包括對主要地理區域的市場表現進行全面檢驗,確定高成長地區和區域趨勢,以更深入地了解區域市場機會。

新趨勢與新機會:識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項:我們提供靈活的報告客製化服務,以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察,以更好地支援您的策略決策。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球動物腸道健康市場:依畜牧類型分類

  • 市場分析、洞察與預測
  • 水產養殖
  • 家禽
  • 反芻動物
  • 豬
  • 其他

第5章:全球動物腸道健康市場:依添加劑分類

  • 市場分析、洞察與預測
  • 益生菌
  • 益生元
  • 活化
  • 植物源

第6章:全球動物腸道健康市場:以劑型分類

  • 市場分析、洞察與預測
  • 乾燥
  • 液體

第7章:全球動物腸道健康市場:依來源分類

  • 市場分析、洞察與預測
  • 微生物
  • 植物來源

第8章:全球動物腸道健康市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第10章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Evonik Industries
    • DSM-Firmenich
    • BASF
    • Kemin Industries
    • Novus International
    • Adisseo
    • Alltech
    • Cargill
    • ADM
    • Nutreco
    • Lallemand Animal Nutrition
    • Phibro Animal Health
    • Chr. Hansen
    • Novozymes
    • IFF
    • Lesaffre
    • Biomin
    • EW Nutrition
    • Huvepharma
    • Zinpro
簡介目錄
Product Code: VMR11214634

The global animal intestinal health market size is expected to reach USD 8.59 Billion in 2034 from USD 4.65 Billion in 2025, growing at a CAGR of 7.06% during 2026-2034.The animal intestinal health market is poised for significant growth, driven by the increasing awareness of the importance of gut health in livestock and companion animals. As the global demand for animal protein rises, producers are increasingly focusing on optimizing animal health and performance to ensure sustainable production. The role of gut health in enhancing nutrient absorption, improving immunity, and reducing disease susceptibility is becoming more recognized, leading to a surge in demand for products that promote intestinal health.

Innovations in probiotics, prebiotics, and other gut health supplements are at the forefront of this market expansion. These products not only support digestive health but also contribute to overall animal well-being, which is critical in a competitive agricultural landscape. The growing trend towards natural and organic farming practices is further driving the demand for gut health solutions that align with these principles, as producers seek to minimize the use of antibiotics and other synthetic additives.

Moreover, the increasing incidence of zoonotic diseases and the rising consumer demand for safe, high-quality animal products are compelling producers to invest in animal health solutions. Regulatory pressures and the need for compliance with food safety standards are also significant factors driving the market. As research continues to unveil the intricate relationship between gut health and overall animal performance, the animal intestinal health market is expected to witness robust growth, with a focus on innovative solutions that cater to the specific needs of different animal species.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Livestock

  • Aquaculture
  • Poultry
  • Ruminant
  • Swine
  • Others

By Additive

  • Probiotics
  • Prebiotics
  • Immunostimulants
  • Phytogenics

By Form

  • Dry
  • Liquid

By Source

  • Microbial
  • Plant-Based

COMPANIES PROFILED

  • Evonik Industries
  • DSM-Firmenich
  • BASF
  • Kemin Industries
  • Novus International
  • Adisseo
  • Alltech
  • Cargill
  • ADM
  • Nutreco
  • Lallemand Animal Nutrition
  • Phibro Animal Health
  • Chr. Hansen
  • Novozymes
  • IFF
  • Lesaffre
  • Biomin
  • EW Nutrition
  • Huvepharma
  • Zinpro

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANIMAL INTESTINAL HEALTH MARKET: BY LIVESTOCK 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Livestock
  • 4.2. Aquaculture Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Poultry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Ruminant Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Swine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET: BY ADDITIVE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Additive
  • 5.2. Probiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Prebiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Immunostimulants Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Phytogenics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET: BY FORM 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Form
  • 6.2. Dry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Liquid Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET: BY SOURCE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Source
  • 7.2. Microbial Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Plant-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Livestock
    • 8.2.2 By Additive
    • 8.2.3 By Form
    • 8.2.4 By Source
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Livestock
    • 8.3.2 By Additive
    • 8.3.3 By Form
    • 8.3.4 By Source
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Spain
    • 8.3.10 Russia
    • 8.3.11 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Livestock
    • 8.4.2 By Additive
    • 8.4.3 By Form
    • 8.4.4 By Source
    • 8.4.5 China
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 India
    • 8.4.9 Australia
    • 8.4.10 South East Asia
    • 8.4.11 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Livestock
    • 8.5.2 By Additive
    • 8.5.3 By Form
    • 8.5.4 By Source
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Livestock
    • 8.6.2 By Additive
    • 8.6.3 By Form
    • 8.6.4 By Source
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ANIMAL INTESTINAL HEALTH INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Evonik Industries
    • 10.2.2 DSM-Firmenich
    • 10.2.3 BASF
    • 10.2.4 Kemin Industries
    • 10.2.5 Novus International
    • 10.2.6 Adisseo
    • 10.2.7 Alltech
    • 10.2.8 Cargill
    • 10.2.9 ADM
    • 10.2.10 Nutreco
    • 10.2.11 Lallemand Animal Nutrition
    • 10.2.12 Phibro Animal Health
    • 10.2.13 Chr. Hansen
    • 10.2.14 Novozymes
    • 10.2.15 IFF
    • 10.2.16 Lesaffre
    • 10.2.17 Biomin
    • 10.2.18 EW Nutrition
    • 10.2.19 Huvepharma
    • 10.2.20 Zinpro